Mackay Shields LLC Abb Vie Inc. Transaction History

Mackay Shields LLC

$581 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $35 Million - $44.5 Million	-254,342 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.32 Million - $1.64 Million	-9,988 Reduced 3.78%	254,342 $41.2 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $650,810 - $823,463	-6,058 Reduced 2.24%	264,330 $35.8 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $831,622 - $944,016	-7,816 Reduced 2.81%	270,388 $29.2 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $11.2 Million - $12.5 Million	-106,918 Reduced 27.76%	278,204 $31.3 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $4.74 Million - $5.22 Million	-46,375 Reduced 10.75%	385,122 $41.7 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $4.87 Million - $6.57 Million	-60,470 Reduced 12.29%	431,497 $46.2 Million
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $12.5 Million - $14.7 Million	-146,081 Reduced 22.89%	491,967 $43.1 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $7.13 Million - $9.54 Million	97,131 Added 17.96%	638,048 $62.6 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $6.89 Million - $10.4 Million	-106,815 Reduced 16.49%	540,917 $41.2 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $5.85 Million - $7.32 Million	81,120 Added 14.32%	647,732 $57.4 Million
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $8.85 Million - $10.6 Million	-140,488 Reduced 19.87%	566,612 $42.9 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1.97 Million - $2.51 Million	29,910 Added 4.42%	707,100 $51.4 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $6 Million - $7.07 Million	77,825 Added 12.98%	677,190 $54.6 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $342,462 - $422,347	-4,399 Reduced 0.73%	599,365 $55.3 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $7.72 Million - $8.59 Million	86,867 Added 16.81%	603,764 $57.1 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $19.4 Million - $22.9 Million	-215,710 Reduced 29.44%	516,897 $47.9 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $67.4 Million - $90.3 Million	732,607 New	732,607 $69.3 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account